COPD: Adherence to therapy

Multidisciplinary Respiratory Medicine

Volumn 9, Issue 1, 2014, Pages

  Sanduzzi, Alessandro ^a   Balbo, Piero ^b   Candoli, Piero ^c   Catapano, Giousuè A ^d   Contini, Paola ^e   Mattei, Alessio ^f   Puglisi, Giovanni ^g   Santoiemma, Luigi ^h   Stanziola, Anna A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c AUSL   (Italy)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^e BELLARIA HOSPITAL   (Italy)

^f MOLINETTE HOSPITAL   (Italy)

^g SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^h ASL   (Italy)

Author keywords

Adherence; COPD; Inhaler; LABA; LAMA; Questionnaire

Indexed keywords

ACLIDINIUM BROMIDE; BUDESONIDE PLUS FORMOTEROL; FLUTICASONE; FORMOTEROL; GLYCOPYRRONIUM BROMIDE; GLYCOPYRRONIUM BROMIDE PLUS INDACATEROL; INDACATEROL; OLODATEROL; OLODATEROL PLUS TIOTROPIUM BROMIDE; SALMETEROL; TIOTROPIUM BROMIDE; UMECLIDINIUM; UMECLIDINIUM PLUS VILANTEROL; VILANTEROL;

AGE; ATTITUDE TO ILLNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMBINATION CHEMOTHERAPY; COMMUNITY LIVING; CULTURAL FACTOR; DEPRESSION; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DRY POWDER INHALER; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; LONG TERM CARE; MEDICATION COMPLIANCE; MONOTHERAPY; PATIENT ATTITUDE; POLYPHARMACY; PRESCRIPTION; QUESTIONNAIRE; REVIEW; SELF CARE; SMOKING; SOFT MIST INHALER; TREATMENT OUTCOME;

EID: 84949794718     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-9-60     Document Type: Review

References (38)

1. Raule G: L'aderenza in Medicina Respiratoria. Programma Educazionale della Società Italiana di Medicina Respiratoria. In Edizione 2011 del Caleidoscopio Pneumologico. Verona: MD per Newtours; 2011.
2. Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 2005, 353(5):487-497.
3. Braido F, Baiardini I, Sumberesi M., Blasi F, Canonica GW: Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. Respir Res 2013, 14:94.
4. Lareau SC, Yawn BP: Improving adherence with inhaler therapy in COPD. Int J Chron Obstruct Pulmon Dis 2010, 5:401-406.
5. World Health Organization: Adherence to long-term therapies: policy for action. In Meeting report 4-5 June 2001.; 2008. Available at: http://www.who.int/chronic-conditions/adherence/en/.
6. Cartabellotta A: La non-compliance alla terapia farmacologica: strategie diagnostico-terapeutiche. Evid Publ GIMBE Found 2013, 5(7):e1000051.
7. Restrepo RD, Alvarez MT, Wittnebel L.D., Sorenson H., Wettstein R, Vines DL, Sikkema-Ortiz J, Gardner D.D., Wilkins RL: Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008, 3:371-384.
8. Charles MS, Blanchette CM, Silver H, Lavallee D., Dalal AA, Mapel D: Adherence to controller therapy for chronic obstructive pulmonary disease: a review. Curr Med Res Opin 2010, 26:2421-2429.
9. Rolnick SJ, Pawloski PA, Hedblom B.D., Asche SE, Bruzek RJ: Patient characteristics associated with medication adherence. Clin Med Res 2013, 11(2):54-65.
10. Rotter JB: Social Learning and Clinical Psychology. New York: Prentice Hall; 1979.
11. Dal Negro R.W., Micheletto C, Tosatto R., Dionisi M, Turco P, Donner CF: Costs of asthma in Italy: results of the SIRIO (Social Impact of Respiratory Integrated Outcomes) study. Respir Med 2007, 101:2511-2519.
12. Ostrowski M: Report takes aim at America's other drug problem: poor adherence. J Fam Pract 2007, 56:734.
13. Unni EJ, Farris KB: Unintentional non-adherence and belief in medicines in older adults. Patient Educ Couns 2011, 83:265-268.
14. Giraud V, Roche N: Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Resp J 2002, 19:246-251.
15. Bandura A: Principles of Behavior Modification. New York: Prentice Hall; 1977.
16. Melani A, Bonavia M, Cilenti V., Cinti C, Lodi M, Martucci P., Serra M, Scichilone N, Sestini P., Aliani M, Neri M, Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri: Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011, 105(6):930-938.
17. Qian J, Simoni-Wastila L, Rattinger G.B., Zuckerman IH, Lehmann S, Wei YJ, Stuart B: Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry 2014, 29:49-57.
18. Sohanpal R, Hooper R, Hames R., Priebe S, Taylor S: Reporting participation rates in studies of non-pharmacological interventions for patients with chronic obstructive pulmonary disease: a systematic review. Syst Rev 2012, 1:66.
19. Toy EL, Beaulieu NU, McHale J.M., Welland TR, Plauschinat CA, Swensen A, Duh MS: Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med 2011, 105(3):435-441.
20. Colthorpe P, Voshaar T, Kieckbusch T., Cuoghi E, Jauernig J: Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium. J Drug Assess 2013, 2:11-16.
21. Anderson P: Use of Respimat Soft Mist Inhaler in COPD patients. Int J Chron Obstruct Pulmon Dis 2006, 1:251-259.
22. Atkins PJ: Dry powder inhalers: an overview. Respir Care 2005, 50:1304-1312.
23. Hill LS, Slater AL: A comparison of the performance of two modern multidose dry powder asthma inhalers. Respir Med 1998, 92(1):105-110.
24. Borgstroem L, Asking L, Thorsson L: Idealhalers or realhalers? A comparison of Diskus and Turbuhaler. Int J Clin Pract 2005, 59:1488-1495.
25. Magnussen H, Watz H, Zimmermann I., Macht S, Greguletz R, Falques M., Jarreta D, Garcia GE: Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPD. Respir Med 2009, 103(12):1832-1837.
26. Newman SP, Sutton DJ, Segarra R, Lamarca R., de Miquel G: Lung deposition of aclidinium bromide from Genuair, a multidose dry powder inhaler. Respiration 2009, 78(3):322-328.
27. Pavkov R, Mueller S, Fiebich K., Singh D, Stowasser F, Pignatelli G., Walter B, Ziegler D, Dalvi M., Dederichs J, Rietveld I: Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol. Curr Med Res Opin 2010, 26(11):2527-2533.
28. Calverley PM, Anderson JA, Celli B, Ferguson G.T., Jenkins C., Jones PW, Yates JC, Vestbo J, TORCH investigators: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356(8):775-789.
29. Almagro P, Salvado M, Garcia-Vidal C, Rodriguez-Carballeira M, Delgado M, Barreiro B., Heredia JL, Soriano JB: Recent improvement in long-term survival after a COPD hospitalisation. Thorax 2010, 65:298-302.
30. Dal Negro R.W., Tognella S, Tosatto R., Dionisi M, Turco P, Donner CF: Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes). Respir Med 2008, 102:92-101.
31. George J, Kong DC, Thoman R, Stewart K: Factors associated with medication non-adherence in patients with COPD. Chest 2005, 128:3198-3204.
32. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24(1):67-74.
33. Barnestein-Fonseca P., Leiva-Fernández J, Vidal-España F: Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study. BMC Pulm Med 2011, 24(11):6.
34. Dalby R, Spallek M, Voshaar T: A review of the development of Respimat Soft MistTM Inhaler. Int J Pharm 2004, 283:1-9.
35. Rosenbaum L, Shrank WH: Taking our medicine - improving adherence in the accountability era. N Engl J Med 2013, 369:694-695.
36. Haynes RB, Montague P, Oliver T., McKibbon KA, Brouwers MC, Kanani R: Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2000, 2:CD000011.
37. Van der Palen J, Klein JJ, Van Herwaarden CL, Zielhuis GA, Seydel ER: Multiple inhalers confuse asthma patients. Eur Respir J 1999, 14(5):1034-1037.
38. Covvey JR, Mullen AB, Ryan M, Steinke D.T., Johnston BF, Wood FT, Boyter AC: A comparison of medication adherence/persistence for asthma and chronic obstructive pulmonary disease in the United Kingdom. Int J Clin Pract 2014, 68:1200-1208.